CNBX Pharmaceuticals Inc. (CNBX)
↓ Download CSV- Sector Manufacturing
- Incorporated NV
- Fiscal year ends Aug 31
In fiscal 2025, CNBX Pharmaceuticals Inc. reported revenue of $0, down 100.0% from the prior year. The company ran a net loss.
Key ratios (FY2025)
-100.0%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $130.1K | $410.2K | $30.0K | $0 | $7.2K | $9.8K | $9.6K | $5.7K | $112.5K |
| Gross Profit | — | — | — | — | — | — | — | — | $5.7K | $112.5K |
| Operating Income | -$271.7K | -$583.1K | -$931.4K | -$2.95M | -$2.60M | -$3.04M | -$3.30M | -$3.81M | -$1.85M | -$280.7K |
| Net Income | -$314.0K | -$695.2K | -$3.71M | -$3.72M | -$3.19M | -$7.47M | $1.13M | -$3.78M | -$1.93M | — |
| EPS (Diluted) | $0.00 | $-0.02 | $-0.42 | $-3.59 | $-0.02 | — | — | — | — | — |
| Total Assets | $18.4K | $31.4K | $499.0K | $811.2K | $3.08M | $2.22M | $15.18M | $3.18M | $3.64M | $23.7K |
| Total Liabilities | — | — | — | — | — | — | — | — | — | $491.2K |
| Shareholders' Equity | -$2.50M | -$2.48M | -$2.02M | $1.63M | $1.81M | $1.76M | $14.74M | $2.65M | -$2.94M | -$467.4K |
| Cash & Equivalents | $15.1K | $26.4K | $129.7K | $117.5K | $1.39M | $777.6K | $266.0K | $1.39M | $1.39M | $19.1K |
| Operating Cash Flow | -$171.3K | -$244.3K | -$112.5K | -$1.68M | -$2.49M | -$2.77M | -$3.09M | -$1.97M | -$863.6K | -$120.1K |
| Shares Outstanding | 553.96M | 31.11M | 22.61M | 1.24M | 148.66M | 135.08M | 134.50M | 121.58M | 119.54M | 107.22M |